# Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

> **NCT02168062** · PHASE2 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 57 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **BEHAVIORAL:** Behavioral Dietary Intervention
- **OTHER:** Counseling
- **OTHER:** Educational Intervention
- **BEHAVIORAL:** Exercise Intervention
- **DRUG:** Goserelin Acetate
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Leuprolide Acetate
- **OTHER:** Quality-of-Life Assessment
- **DRUG:** Triptorelin Pamoate

## Key facts

- **NCT ID:** NCT02168062
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06-16
- **Primary completion:** 2018-05-22
- **Final completion:** 2018-05-22
- **Target enrollment:** 57 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2020-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168062, "Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02168062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*